Precision Wealth Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$756K Buy
630
+15
+2% +$15.3K 0.23% 97
2026
Q1
$566K Sell
615
-50
-8% -$50.7K 0.19% 113
2025
Q4
$714K Sell
665
-81
-11% -$77.5K 0.23% 97
2025
Q3
$569K Sell
746
-34
-4% -$25.3K 0.18% 119
2025
Q2
$608K Buy
+780
New +$606K 0.2% 92

Other funds holding LLY

Precision Wealth Strategies's LLY Position: Q2 2026 in Review

Precision Wealth Strategies increased its Eli Lilly (LLY) stake by 2.4% in Q2 2026, buying an estimated $15.3K and bringing the position to 630 shares worth $756K. The position accounts for 0.23% of the portfolio, ranked #97.

Precision Wealth Strategies first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Precision Wealth Strategies held 630 shares of Eli Lilly worth $756K as of Q2 2026.
  • Precision Wealth Strategies bought 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.23% of Precision Wealth Strategies's portfolio in Q2 2026, its #97 holding.
  • Precision Wealth Strategies first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Precision Wealth Strategies's 13F filing for Q2 2026, filed 10 Aug 2026.